Prathiba Singh, Vaidyanathan, Sibal win biosimilar drug battle for Biocon, Mylan in Delhi HC

The Delhi High Court yesterday gave the go-ahead to Bangalore-based pharma company Biocon and US-based Mylan Inc. to manufacture and sell their biosimilar drugs for the treatment of early breast cancer and metastatic gastric cancer.

Want to read the full story?

We’re glad you’re enjoying this story. Subscribe to any of our plans to continue reading the story.

Already have an account? Sign In

Related Stories

No stories found.
Bar and Bench - Indian Legal news
www.barandbench.com